Brain Tissue Iron Mirrors Parkinson's Disease Cognitive Involvement
By MedImaging International staff writers Posted on 02 Mar 2020 |
Image: Iron depositions in the brain can track Parkinson’s evolvement (Photo courtesy of UCL)
Magnetic resonance imaging (MRI) quantitative susceptibility mapping (QSM) can detect brain tissue iron changes related to cognitive decline in Parkinson's disease (PD), according to a new study.
Researchers at University College London (UCL, United Kingdom) conducted a study involving 97 patients with early-stage to mid-stage PD, and 37 age-matched controls. The patients were evaluated using the Montreal Cognitive Assessment (MoCA) algorithm for risk of cognitive decline in PD, measures of visuoperceptual function, and the Movement Disorders Society Unified Parkinson’s Disease Rating Scale part 3 (UPDRS-III). They then investigated associations between these measures and QSM, an MRI technique sensitive to brain tissue iron content.
The results showed QSM increases--consistent with higher brain tissue iron content--in PD, in the prefrontal cortex and putamen. Whole brain regression analyses within the PD group identified QSM increases linked with lower MoCA scores in the hippocampus and thalamus; with poorer visual function and higher dementia risk scores in the parietal, frontal, and medial occipital cortices; and with higher UPDRS-III scores in the putamen. Atrophy, as measured using voxel-based morphometry, showed no differences between groups, or association with clinical measures. The study was published on February 20, 2020, in BMJ Journal of Neurology, Neurosurgery, and Psychiatry.
“Iron in the brain is of growing interest to people researching neurodegenerative diseases such as Parkinson's and dementias,” said senior author Rimona Weil, PhD, of the UCL Queen Square Institute of Neurology. “As you get older, iron accumulates in the brain, but it's also linked to the build-up of harmful brain proteins, so we're starting to find evidence that it could be useful in monitoring disease progression, and potentially even in diagnostics.”
“We were surprised at how well the iron levels measured in different regions of the brain with MRI were correlated with cognitive and motor skills,” said study co-author Julio Acosta-Cabronero, PhD, of the UCL Wellcome Centre for Human Neuroimaging. “We hope that brain iron measurement could be useful for a wide range of conditions, such as to gauge dementia severity or to see which brain regions are affected by other movement, neuromuscular, and neuroinflammatory disorders, stroke, traumatic brain injury and drug abuse.”
QSM is an emerging MRI technique which detects local variations in iron content through its sensitivity to magnetic susceptibility differences between chemical species, which are captured by the signal phase of MRI gradient echo sequences. QSM recovers local susceptibility sources giving rise to magnetic field perturbations, which are increased in basal ganglia regions in PD, but it has so far never been used to track cognitive changes in PD.
Related Links:
University College London
Researchers at University College London (UCL, United Kingdom) conducted a study involving 97 patients with early-stage to mid-stage PD, and 37 age-matched controls. The patients were evaluated using the Montreal Cognitive Assessment (MoCA) algorithm for risk of cognitive decline in PD, measures of visuoperceptual function, and the Movement Disorders Society Unified Parkinson’s Disease Rating Scale part 3 (UPDRS-III). They then investigated associations between these measures and QSM, an MRI technique sensitive to brain tissue iron content.
The results showed QSM increases--consistent with higher brain tissue iron content--in PD, in the prefrontal cortex and putamen. Whole brain regression analyses within the PD group identified QSM increases linked with lower MoCA scores in the hippocampus and thalamus; with poorer visual function and higher dementia risk scores in the parietal, frontal, and medial occipital cortices; and with higher UPDRS-III scores in the putamen. Atrophy, as measured using voxel-based morphometry, showed no differences between groups, or association with clinical measures. The study was published on February 20, 2020, in BMJ Journal of Neurology, Neurosurgery, and Psychiatry.
“Iron in the brain is of growing interest to people researching neurodegenerative diseases such as Parkinson's and dementias,” said senior author Rimona Weil, PhD, of the UCL Queen Square Institute of Neurology. “As you get older, iron accumulates in the brain, but it's also linked to the build-up of harmful brain proteins, so we're starting to find evidence that it could be useful in monitoring disease progression, and potentially even in diagnostics.”
“We were surprised at how well the iron levels measured in different regions of the brain with MRI were correlated with cognitive and motor skills,” said study co-author Julio Acosta-Cabronero, PhD, of the UCL Wellcome Centre for Human Neuroimaging. “We hope that brain iron measurement could be useful for a wide range of conditions, such as to gauge dementia severity or to see which brain regions are affected by other movement, neuromuscular, and neuroinflammatory disorders, stroke, traumatic brain injury and drug abuse.”
QSM is an emerging MRI technique which detects local variations in iron content through its sensitivity to magnetic susceptibility differences between chemical species, which are captured by the signal phase of MRI gradient echo sequences. QSM recovers local susceptibility sources giving rise to magnetic field perturbations, which are increased in basal ganglia regions in PD, but it has so far never been used to track cognitive changes in PD.
Related Links:
University College London
Latest General/Advanced Imaging News
- Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques